MediciNova Inc MNOV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $1.32
- Day Range
- $1.32–1.36
- 52-Week Range
- $1.26–2.66
- Bid/Ask
- $1.30 / $1.33
- Market Cap
- $65.23 Mil
- Volume/Avg
- 2,119 / 51,990
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 64.74
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 13
- Website
- https://www.medicinova.com
Comparables
Valuation
|
Metric
|
MNOV
|
EWTX
|
IMVT
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 1.04 | 3.52 | 5.93 |
Price/Sales | 64.74 | — | — |
Price/Cash Flow | — | — | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
MNOV
|
EWTX
|
IMVT
|
|---|---|---|---|
Quick Ratio | 15.55 | 18.98 | 21.56 |
Current Ratio | 15.61 | 19.50 | 22.14 |
Interest Coverage | — | — | — |
Quick Ratio
MNOV
EWTX
IMVT
Profitability
|
Metric
|
MNOV
|
EWTX
|
IMVT
|
|---|---|---|---|
Return on Assets (Normalized) | −10.99% | −24.36% | −43.33% |
Return on Equity (Normalized) | −11.59% | −25.87% | −47.83% |
Return on Invested Capital (Normalized) | −13.69% | −29.82% | −52.69% |
Return on Assets
MNOV
EWTX
IMVT
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Pmwqqrkgq | Wvjsj | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Scjpbvxwj | Nwrfvt | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Mlnqrfkn | Bhcfbg | $97.8 Bil | |
MRNA
| Moderna Inc | Sqvdrnh | Thrpr | $38.8 Bil | |
ARGX
| argenx SE ADR | Lgcnssvxk | Nqjsy | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Bjpjtwyxd | Dlxyb | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Clsrghy | Fptflq | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Lpnzpzzgc | Nmwvkff | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Nmypfpvkcx | Gbvjb | $12.5 Bil | |
INCY
| Incyte Corp | Npkhghgx | Gdwzxm | $11.5 Bil |